Hyperion Defi (HYPD) FCF Margin Growth (5y) (2026)
Hyperion Defi (HYPD) FCF Margin Growth (5y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Hyperion Defi | 46.49 Mn | 36.85 Mn | 357,693.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -53,042.00 |
| Mar 31, 2026 | -147,082.00 |